LGVN
USDLongeveron Inc. Class A Common Stock
$0.800-0.020 (-2.439%)
Precio en Tiempo Real
Healthcare
Biotecnología
Estados Unidos
Gráfico de Precios
Loading Chart...
Métricas Clave
Métricas de Mercado
Apertura
$0.820
Máximo
$0.820
Mínimo
$0.800
Volumen
0.38M
Fundamentos de la Empresa
Capitalización de Mercado
16.8M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.95M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Mínimo $0.633Actual $0.800Máximo $2.31
Noticias Relacionadas
GlobeNewswire
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions,
Ver más
GlobeNewswire
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect
Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHSFull enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II)
Ver más
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.